BR0307620A - Gene streptomyces avermitilis que dirige a razão de avermectinas b2:b1 - Google Patents
Gene streptomyces avermitilis que dirige a razão de avermectinas b2:b1Info
- Publication number
- BR0307620A BR0307620A BR0307620-2A BR0307620A BR0307620A BR 0307620 A BR0307620 A BR 0307620A BR 0307620 A BR0307620 A BR 0307620A BR 0307620 A BR0307620 A BR 0307620A
- Authority
- BR
- Brazil
- Prior art keywords
- ratio
- avermectins
- avermitilis
- drives
- streptomyces avermitilis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
- C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
- C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
"GENE STREPTOMYCES AVERMITILIS QUE DIRIGE A RAZãO DE AVERMECTINAS B2:B1". A presente invenção refere-se a moléculas de polinucleotídeo compreendendo seq³ências de nucleotídeos codificando um produto gene avec, cujas moléculas de polinucleotídeo podem ser usadas para alterar a razão ou quantidade da classe 2:1 de avermectinas produzida em culturas de fermentação de S. avermitilis. A presente invenção refere-se ainda a vetores, células hospedeiras, e cepas mutantes de S. avermitilis em que o gene avec tenha sido inativado ou submetido à mutação de modo a modificar a razão ou quantidade de avermectina da classe 2:1 produzida.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35622202P | 2002-02-12 | 2002-02-12 | |
| PCT/IB2003/000348 WO2003068955A2 (en) | 2002-02-12 | 2003-01-31 | Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR0307620A true BR0307620A (pt) | 2004-12-07 |
| BRPI0307620B1 BRPI0307620B1 (pt) | 2015-08-11 |
| BRPI0307620B8 BRPI0307620B8 (pt) | 2016-09-13 |
Family
ID=27734621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0307620A BRPI0307620B8 (pt) | 2002-02-12 | 2003-01-31 | moléculas de polinucleotídeo codificando variantes de avec, métodos para produzir uma cepa recombinante de streptomyces avermitilis, bem como as referidas células recombinantes e composição de avermectinas |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7388085B2 (pt) |
| EP (2) | EP1476539B1 (pt) |
| JP (1) | JP2005517406A (pt) |
| KR (1) | KR100718378B1 (pt) |
| CN (2) | CN102392028B (pt) |
| AR (1) | AR038405A1 (pt) |
| AT (2) | ATE426659T1 (pt) |
| AU (1) | AU2003245052B2 (pt) |
| BR (1) | BRPI0307620B8 (pt) |
| CA (1) | CA2475214C (pt) |
| CY (2) | CY1110454T1 (pt) |
| DE (1) | DE60326824D1 (pt) |
| DK (2) | DK1476539T3 (pt) |
| ES (2) | ES2373629T3 (pt) |
| IL (3) | IL162866A0 (pt) |
| ME (1) | ME00472B (pt) |
| MX (1) | MXPA04007777A (pt) |
| PL (1) | PL211693B1 (pt) |
| PT (2) | PT1476539E (pt) |
| RS (1) | RS50813B (pt) |
| RU (1) | RU2293117C2 (pt) |
| SI (2) | SI2050815T1 (pt) |
| TW (1) | TWI341330B (pt) |
| WO (1) | WO2003068955A2 (pt) |
| ZA (1) | ZA200405345B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1476539E (pt) * | 2002-02-12 | 2009-04-09 | Pfizer Prod Inc | Gene streptomyces avermitilis que dirige a proporção de avermectinas b2:b1 |
| CN102241750B (zh) * | 2010-05-14 | 2014-05-28 | 中国科学院微生物研究所 | 一种生产阿维菌素的基因工程方法及其专用菌株 |
| CN102093997B (zh) * | 2010-12-01 | 2013-03-13 | 中国科学院上海有机化学研究所 | 一种改造除虫链霉菌产生多拉菌素的方法 |
| CN109576196B (zh) * | 2019-01-25 | 2022-01-04 | 北大方正集团有限公司 | 一种生产多拉菌素的发酵培养基及多拉菌素的生产方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE434277B (sv) | 1976-04-19 | 1984-07-16 | Merck & Co Inc | Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis |
| US4429042A (en) | 1978-09-08 | 1984-01-31 | Merck & Co., Inc. | Strain of Streptomyces for producing antiparasitic compounds |
| IN167980B (pt) | 1987-01-23 | 1991-01-19 | Pfizer | |
| US5252474A (en) | 1989-03-31 | 1993-10-12 | Merck & Co., Inc. | Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use |
| RU2120943C1 (ru) * | 1993-10-05 | 1998-10-27 | Пфайзер Инк. | Производные дорамектина, способы их получения, способы лечения |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| CN1521180A (zh) | 1998-02-13 | 2004-08-18 | �Ʒ� | 介导除虫菌素b2：b1比例的除虫链霉菌基因 |
| US6248579B1 (en) * | 1998-02-13 | 2001-06-19 | Pfizer Inc | Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| RU2156301C2 (ru) * | 1998-06-09 | 2000-09-20 | Мосин Владимир Александрович | Штамм актиномицета streptomyces avermitilis ссм 4697 - продуцент авермектинов |
| US6197591B1 (en) | 1998-09-14 | 2001-03-06 | Pfizer Inc. | Streptomyces avermitilis regulatory genes for increased avermectin production |
| BRPI0013119B8 (pt) * | 1999-08-12 | 2021-05-25 | Pah Usa 15 Llc | molécula polinucleotídica isolada, vetor recombinante purificado, célula hospedeira procariótica e célula de streptomyces avermitilis mutada, método para obtenção de uma nova cepa de s. avermitilis e processo para produção de avermectinas |
| HK1045507A1 (zh) | 1999-08-12 | 2002-11-29 | Vertex Pharmaceuticals Incorporated | C-jun n-末端激酶(jnk)及其他蛋白质激酶的抑制物 |
| PT1476539E (pt) * | 2002-02-12 | 2009-04-09 | Pfizer Prod Inc | Gene streptomyces avermitilis que dirige a proporção de avermectinas b2:b1 |
-
2003
- 2003-01-31 PT PT03739390T patent/PT1476539E/pt unknown
- 2003-01-31 EP EP03739390A patent/EP1476539B1/en not_active Expired - Lifetime
- 2003-01-31 SI SI200332087T patent/SI2050815T1/sl unknown
- 2003-01-31 KR KR1020047012437A patent/KR100718378B1/ko not_active Expired - Lifetime
- 2003-01-31 ES ES09150098T patent/ES2373629T3/es not_active Expired - Lifetime
- 2003-01-31 BR BRPI0307620A patent/BRPI0307620B8/pt not_active IP Right Cessation
- 2003-01-31 AT AT03739390T patent/ATE426659T1/de active
- 2003-01-31 SI SI200331553T patent/SI1476539T1/sl unknown
- 2003-01-31 CA CA2475214A patent/CA2475214C/en not_active Expired - Lifetime
- 2003-01-31 PT PT09150098T patent/PT2050815E/pt unknown
- 2003-01-31 ME MEP-2008-730A patent/ME00472B/me unknown
- 2003-01-31 PL PL371320A patent/PL211693B1/pl unknown
- 2003-01-31 EP EP09150098A patent/EP2050815B1/en not_active Expired - Lifetime
- 2003-01-31 JP JP2003568070A patent/JP2005517406A/ja active Pending
- 2003-01-31 CN CN2011102082591A patent/CN102392028B/zh not_active Expired - Lifetime
- 2003-01-31 RS YUP-700/04A patent/RS50813B/sr unknown
- 2003-01-31 ES ES03739390T patent/ES2321827T3/es not_active Expired - Lifetime
- 2003-01-31 IL IL16286603A patent/IL162866A0/xx unknown
- 2003-01-31 DK DK03739390T patent/DK1476539T3/da active
- 2003-01-31 AT AT09150098T patent/ATE530645T1/de active
- 2003-01-31 CN CN038037416A patent/CN1630712B/zh not_active Expired - Lifetime
- 2003-01-31 DK DK09150098.3T patent/DK2050815T3/da active
- 2003-01-31 RU RU2004124521/13A patent/RU2293117C2/ru active
- 2003-01-31 MX MXPA04007777A patent/MXPA04007777A/es active IP Right Grant
- 2003-01-31 DE DE60326824T patent/DE60326824D1/de not_active Expired - Lifetime
- 2003-01-31 AU AU2003245052A patent/AU2003245052B2/en not_active Expired
- 2003-01-31 WO PCT/IB2003/000348 patent/WO2003068955A2/en not_active Ceased
- 2003-02-10 US US10/361,376 patent/US7388085B2/en not_active Expired - Lifetime
- 2003-02-10 TW TW092102676A patent/TWI341330B/zh not_active IP Right Cessation
- 2003-02-10 AR ARP030100408A patent/AR038405A1/es active IP Right Grant
-
2004
- 2004-07-05 IL IL162866A patent/IL162866A/en active IP Right Grant
- 2004-07-05 ZA ZA200405345A patent/ZA200405345B/xx unknown
-
2008
- 2008-04-23 US US12/107,949 patent/US8008078B2/en not_active Expired - Fee Related
- 2008-06-22 IL IL192371A patent/IL192371A/en active IP Right Grant
-
2009
- 2009-04-27 CY CY20091100467T patent/CY1110454T1/el unknown
-
2011
- 2011-12-02 CY CY20111101193T patent/CY1112491T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lai et al. | Structure of an inducibly methylatable nucleotide sequence in 23S ribosomal ribonucleic acid from erythromycin-resistant Staphylococcus aureus | |
| BRPI0417710A (pt) | usos de um ácido nucleico, de uma unidade de expressão, e da seqüência de ácido nucleico, ácido nucleico, unidade de expressão, métodos para alterar ou induzir as taxas de transcrição e de expressão de genes em microorganismos comparado com o tipo selvagem, e para preparar produtos biossintéticos, lisina, metionina, e treonina, cassete de expressão, vetor de expressão, microorganismo geneticamente modificado, e, unidade de expressão | |
| Yamashita et al. | Genes involved in cell wall localization and side chain formation of rhamnose-glucose polysaccharide in Streptococcus mutans | |
| BR9910038A (pt) | Fragmento de ácido nucléico isolado, gene quimérico, célula hospedeira transformada polipeptìdio, método de alteração do nìvel de expressão de uma enzina, método de obtenção de um fragmento de ácido nucléico, produto e método de avaliação de pelo menos um composto quanto à sua capacidade de inibir a atividade de uma enzima | |
| BR0003943A (pt) | Sequências de nucleotìdeo que codificam para o gene thre e processo para a produção enzimática de l-treonina usando bactérias corineforma | |
| BRPI0417728A (pt) | uso de um ácido nucleico e de uma unidade de expressão, ácido nucleico, unidade de expressão, método para alterar ou induzir a taxa de transcrição de genes em microorganismos, cassete de expressão, vetor de expressão, microorganismo geneticamente modificado, método para preparar produtos biossintéticos e uso de uma seqüência de ácido nucleico | |
| EP0792375A4 (en) | ENZYMACTIVE DNA MOLECULES | |
| Cogulu et al. | Genotyping of Streptococcus mutans by using arbitrarily primed polymerase chain reaction in children with Down Syndrome | |
| BR9907893A (pt) | Gene de streptomyces avermitilis que dirige a proporção de avermectinas b2:b1 | |
| UY26287A1 (es) | Gen de streptomyces avermitilis que que dirige la relación de avermectinas b2:b1 | |
| BR0013119A (pt) | Gene de streptomyces avermitilis que regula a proporção de avermectinas b2:bl | |
| BRPI0307620B8 (pt) | moléculas de polinucleotídeo codificando variantes de avec, métodos para produzir uma cepa recombinante de streptomyces avermitilis, bem como as referidas células recombinantes e composição de avermectinas | |
| KR910004807A (ko) | 변형된 dna 및 그 용도 | |
| BR0110128A (pt) | Mutante de bactéria láctica superprodutora de exopolissacarìdeos, utilização do mesmo e ácido nucleico codificando uma alfa-fosfoglucomutase | |
| CO4340655A1 (es) | Genes que codifican el complejo alfa-cetoacido deshidrogena- sa de cadena ramificada de streptomyces avermitilis | |
| WO2021243174A3 (en) | Differential knockout of a heterozygous allele of samd9l | |
| BRPI0409192A (pt) | microorganismo contendo genes tdcbc/pcka inativados e método de produção de l-treonina usando o mesmo | |
| WO2002086067A3 (en) | Mycobacterial sulfation pathway proteins and methods of use thereof | |
| WO2002010203A3 (en) | Daz genes | |
| Chop | Regulation of pho Regulon Gene Expression by the Carbon Control Protein A, CcpA, in Bacillus subtilis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: PAH USA 15 LLC (US) |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B25D | Requested change of name of applicant approved |
Owner name: ZOETIS P LLC (US) |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/08/2015, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REFERENTE AO DESPACHO 16.1 PUBLICADO NA RPI 2327 DE 11.08.2015, QUANTO A FORMATACAO DO DOCUMENTO |
|
| B25A | Requested transfer of rights approved | ||
| B25G | Requested change of headquarter approved | ||
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 11/08/2025 |